2.3Impact Factor
3.5CiteScore
24 daysTime to First Decision

Advances in Respiratory Medicine, Volume 93, Issue 1

February 2025 - 5 articles

Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
You may sign up for email alerts to receive table of contents of newly released issues.
PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (5)

Select all

Article

1,760 Views

14 Pages

Are There Differences in Postural Control and Muscular Activity in Individuals with COPD and with and Without Sarcopenia?

Walter Sepúlveda-Loyola,
Alejandro Álvarez-Bustos,
Juan José Valenzuela-Fuenzalida,
Carla María Ordinola Ramírez,
Carol Saldías Solis and
Vanessa Suziane Probst

Adv. Respir. Med.2025, 93(1), 5;https://doi.org/10.3390/arm93010005

18 February 2025

Aim: The aim of this study was to compare balance performance and electromyographic activity in individuals with COPD, with and without sarcopenia. Method: Thirty-five patients with COPD were classified with and without sarcopenia according to EWGSOP...

Full Article

Review

2,609 Views

22 Pages

A Meta-Analysis of the Impact of Using Angiotensin-Converting Enzyme Inhibitors (ACEIs) or Angiotensin II Receptor Blockers (ARBs) on Mortality, Severity, and Healthcare Resource Utilization in Patients with COVID-19

Ruijuan Li,
Jie Zhang and
Liang Ren

Adv. Respir. Med.2025, 93(1), 4;https://doi.org/10.3390/arm93010004

18 February 2025

Objective: The primary objective of this study is to explore the potential link between the utilization of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs) and its impact on mortality, disease severity, and...

Full Article

Article

1,945 Views

11 Pages

Prospective, Open-Label, Observational, Multicenter, Single Arm, Post-Marketing Study in Asthmatic Patients for Evaluation of Safety and Effectiveness of Indacaterol/Mometasone DPI (PROMISING-SHIFT)

Saurabh Karmakar,
Gajendra V. Singh,
Amit S. Bhate,
Vijaykumar Barge,
Bharat Mehrotra,
Chintan Patel,
Ekta Sinha,
Sagar Bhagat,
Saiprasad Patil and
Hanmant Barkate

Adv. Respir. Med.2025, 93(1), 3;https://doi.org/10.3390/arm93010003

6 February 2025

Background: Asthma significantly impacts global health, necessitating effective management strategies. A combination of inhaled corticosteroids (ICSs) and long-acting β2-agonists (LABA) is recommended for patients with inadequately controlled as...

Full Article

Article

2 Citations

1,711 Views

11 Pages

The Role of Impulse Oscillometry in Detection of Preserved Ratio Impaired Spirometry (PRISm)

Chalerm Liwsrisakun,
Warawut Chaiwong,
Athavudh Deesomchok,
Pilaiporn Duangjit and
Chaicharn Pothirat

Adv. Respir. Med.2025, 93(1), 2;https://doi.org/10.3390/arm93010002

27 January 2025

Background: Information is limited regarding the role of impulse oscillometry (IOS) for the detection of preserved ratio impaired spirometry (PRISm). Therefore, we aimed to study the diagnostic ability of IOS in differentiating between PRISm and heal...

Full Article

Communication

1,268 Views

7 Pages

Evaluating the Effect of Body Mass Index on Procalcitonin Level in Patients with Pneumonia: A Retrospective Cross-Sectional Study

Mohammad Z. Khrais,
J. Curran Henson,
Jake Smith and
Nikhil Meena

Adv. Respir. Med.2025, 93(1), 1;https://doi.org/10.3390/arm93010001

26 January 2025

Procalcitonin (PCT) is commonly used to evaluate the etiology and severity of pneumonia. PCT has been shown to be elevated at baseline in patients with obesity. The aim of this study is to determine if body mass index (BMI) has an influence on admiss...

Full Article

Get Alerted

Add your email address to receive forthcoming issues of this journal.

Adv. Respir. Med. - ISSN 2543-6031

Imprint

Download Flyer